Recombinant human growth hormone (rHGH, sold as somatropin) is one of the most over-promised drugs in the physique and anti-ageing world. It is a real hormone with real effects, but the gap between what it demonstrably does and what it is sold to do is enormous. This guide lays out the honest version: what the evidence supports, what the trade-offs are, and why the results are slower, smaller, and more expensive than the marketing implies.
The one-line summary: HGH reliably shifts fluid and, over months, modestly changes fat and lean tissue, but it is not a fast or dramatic muscle-builder in healthy adults, and it comes with a metabolic cost that is easy to underestimate.
What HGH actually is
Growth hormone is a peptide hormone secreted in pulses by the pituitary, largest during deep sleep. It acts partly on its own receptors and partly by driving the liver and other tissues to produce insulin-like growth factor 1 (IGF-1), which mediates most of its anabolic and growth-promoting effects. Injecting somatropin bypasses the body's own pulsatile control and raises GH — and therefore IGF-1 — for hours at a time.
Because so much of GH's action runs through IGF-1, people track IGF-1 blood levels as a proxy for dose response. This matters later, because the same IGF-1 axis that drives the wanted effects also drives most of the unwanted ones.
What it does vs what it is marketed to do
Here is the split that matters most:
- Fat loss: real but modest. Controlled studies in adults show GH reduces fat mass, particularly visceral fat, and this is genuine. But the effect over realistic timeframes is measured in low single-digit kilograms, not the transformations shown in advertising.
- Lean mass: mostly water, not muscle. The rapid "gains" people notice in the first weeks are largely fluid retention and increased lean body mass on a scale — not a proportional increase in contractile muscle or strength. Studies in healthy adults consistently find little to no improvement in muscle strength or athletic performance from GH alone.
- Recovery and connective tissue: plausible, under-proven. GH and IGF-1 are involved in collagen and connective-tissue turnover, and some users report better recovery. Controlled human evidence that it accelerates injury healing in otherwise healthy people is thin.
- Anti-ageing and skin: marketing, not medicine. Claims about reversing ageing rest on a small, old study and a lot of extrapolation; the side-effect load in older adults was significant.
The IGF-1 axis and why it cuts both ways
The therapeutic effects and the side effects share a mechanism. Raising IGF-1 promotes tissue growth and fluid handling; push it high enough for long enough and you get the classic acromegaly-adjacent problems: soft-tissue swelling, joint aches, nerve compression. This is why chasing high IGF-1 numbers tends to buy more side effects than benefit past a certain point.
Side effects people actually get
- Fluid retention and oedema. The most common early effect — puffiness in the hands, feet, and face, sometimes with a bloated look that gets mistaken for growth.
- Carpal tunnel syndrome. Swelling in the wrist compresses the median nerve, producing numbness, tingling, and hand weakness; it is dose-related and usually reverses when the dose drops.
- Insulin resistance. GH is counter-regulatory to insulin. It raises blood glucose and reduces insulin sensitivity, which is a real metabolic downside and a particular concern for anyone predisposed to diabetes. This is also why HGH is sometimes stacked with insulin in physique circles — a combination that meaningfully increases hypoglycaemia risk and is not something to treat casually.
- Joint pain and stiffness. Common enough to be a frequent reason people stop.
- Numb, tingling extremities and headaches. Reported regularly at higher doses.
Cost and time to effect — the unglamorous part
Two realities the marketing skips. First, HGH is slow: meaningful body-composition change requires consistent daily use over many months, not weeks. Anyone expecting a visible payoff in a month is misjudging the pharmacology. Second, it is expensive and dosed daily, so the real-world cost over the months it takes to work is substantial — far more than most other physique drugs for a comparatively subtle effect. That cost-to-benefit ratio is the honest reason many experienced users conclude it is not worth it for physique alone.
Legal and sporting status
Somatropin is a prescription medicine approved for genuine growth hormone deficiency and a handful of other conditions — not for bodybuilding or anti-ageing. In sport, GH is prohibited at all times under the WADA Prohibited List (class S2), and validated tests exist to detect it. Non-prescription "HGH" sold online is also a common target for counterfeiting, so identity and purity are frequently not what the label claims.
Bottom line
Exogenous HGH does real things: it lowers fat, especially visceral fat, and raises lean body mass mostly through fluid, over months of daily use. What it does not do is build significant muscle or strength in healthy adults, work quickly, or come cheap — and it reliably brings fluid retention, carpal tunnel, joint pain, and insulin resistance along the way. Judged honestly against its cost and side effects, it is a slow, expensive, modest tool, not the physique shortcut it is marketed as.